Scholarly Index
John R. Sims
Eli Lilly (United States); 12,512 total citations; 205 total publications; best world rank #79
Eli Lilly (United States)
12,512Total citations
205Total publications
44H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Alzheimer's disease research and treatments | 2021-2025 | 155 | US 68 | 98.29 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 195 | US 85 | 98.10 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 79 | US 9 | 94.68 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 787 | US 256 | 94.01 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 657 | US 215 | 81.20 |
| Statistical Methods in Clinical Trials | 2021-2025 | 491 | US 211 | 78.73 |